FDA Inspection 789299 — Rebgro Corporation

Rebgro Corporation — FEI 3007704373

The FDA completed an inspection of Rebgro Corporation on Jun 27, 2012 in Roebling, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 27, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Roebling, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
121521 CFR 211.67(b)Written procedures not established/followed
197521 CFR 211.182Written records kept in individual logs
358521 CFR 211.110(a)Control procedures to monitor and validate performance
437621 CFR 211.188(b)(4)Weights and measures of components used

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.